| 07/02/2025 16:00 |
Notice Regarding the Status of Share Buyback (Share Buyback Based on Article 165, Paragraph 2 of the Companies Act) |
| 06/27/2025 16:15 |
Corporate Governance Report |
| 06/26/2025 16:30 |
Announcement on Granting Share Remuneration-Type Stock Options to Subsidiaries' Directors and Subsidiaries' Employees (Nonresidents) |
| 06/26/2025 16:30 |
Announcement on Granting Share Remuneration-Type Stock Options (Share Acquisition Rights) to Executive Officers, Directors, and Employees |
| 06/19/2025 17:00 |
Notice Regarding the Resolution on Share Buyback (Share Buyback Based on Article 165, Paragraph 2 of the Companies Act) |
| 06/10/2025 10:00 |
Announcement Regarding the Conclusion of an MOU with Dr. Agarwals Eye Hospital in the myopia control management field in India |
| 06/03/2025 08:00 |
NOTICE OF THE 68TH ANNUAL GENERAL MEETING OF SHAREHOLDERS |
| 05/20/2025 16:00 |
Our Views on Questions from Shareholders and Investors for the Year Ended March 31, 2025 |
| 05/20/2025 16:00 |
Notice of Receipt of Dividend from a Subsidiary Company |
| 05/14/2025 14:00 |
Notice of Recording Extraordinary Income (Gain on Reversal of Share Acquisition Rights) |
| 05/14/2025 14:00 |
Consolidated Financial Results for the Year Ended March 31, 2025 |
| 05/14/2025 14:00 |
MeniconIR_Mid-term Management Plan (Growth Strategy Targets Update) |
| 05/14/2025 14:00 |
Consolidated Financial Results for the Year Ended March 31, 2025 [Japanese GAAP] |
| 05/14/2025 14:00 |
Notice of Agenda Items for the 68th Annual General Meeting of Shareholders (Election of Directorsand Granting Stock Options (Stock Acquisition Rights) |
| 04/30/2025 16:00 |
Notice of Recording Expenses Extraordinary Losses Associated with Structural Reforms, Revision of Consolidated Financial Forecasts for the Fiscal Year |
| 04/21/2025 10:00 |
Announcement of Price Revisions |
| 03/18/2025 10:00 |
Notice of Taking Residence in Open Innovation Base "STATION Ai," Which Supports the Creation of New Businesses |
| 02/26/2025 18:00 |
Notice Regarding Personnel Changes in Executive Officers |
| 02/20/2025 17:00 |
Our Views on Questions from Shareholders and Investors |
| 02/14/2025 14:00 |
Consolidated Financial Results for the Nine Months Ended December 31, 2024 |
| 02/14/2025 14:00 |
Consolidated Financial Results for the Nine Months Ended December 31, 2024 [Japanese GAAP] |
| 01/29/2025 15:30 |
Notice Concerning Redemption at Maturity of \23,000,000,000 Zero Coupon Convertible Bonds due 2025 |
| 12/24/2024 18:30 |
Notice Regarding Change in Director and Representative Executive Officers (Resignation) |
| 12/13/2024 16:15 |
Corporate Governance Report |
| 11/13/2024 14:00 |
Consolidated Financial Results for the Six Months Ended September 30, 2024 |
| 11/13/2024 14:00 |
Consolidated Financial Results for the Six Months Ended September 30, 2024 [Japanese GAAP] |
| 11/07/2024 10:00 |
Conclusion of a strategic partnership with Sigo for selling disposable contact lenses in the Chinese market |
| 10/31/2024 00:30 |
MENICON REPORT 2024 |
| 10/11/2024 10:45 |
Announcement regarding issuance of 3rd Unsecured Straight Bonds |
| 10/01/2024 11:00 |
Announcement of used disposable contact lens case collection aiming for environment-friendly contact lens distribution |
| 10/01/2024 10:00 |
Announcement of acquisition of shares of the distributors owned by Oculus in Southeast Asia |
| 08/09/2024 14:00 |
Consolidated Financial Results for the Three Months Ended June 30, 2024 |
| 08/09/2024 14:00 |
Consolidated Financial Results for the Three Months Ended June 30, 2024 [Japanese GAAP] |
| 08/01/2024 17:00 |
Announcement on the Determination of Details for Issuing Share Remuneration-Type Stock Options (Share Acquisition Rights) |
